(META) Meta Platforms - Ratings and Ratios
Social Media Apps, Virtual Reality, Augmented Reality, Mixed Reality, Wearables
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.31% |
| Yield on Cost 5y | 0.80% |
| Yield CAGR 5y | 5.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 7.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 31.2% |
| Value at Risk 5%th | 47.4% |
| Relative Tail Risk | -7.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -16.20 |
| CAGR/Max DD | 1.95 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.510 |
| Beta | 1.405 |
| Beta Downside | 1.386 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.15% |
| Mean DD | 6.59% |
| Median DD | 4.36% |
Description: META Meta Platforms January 27, 2026
Meta Platforms, Inc. (NASDAQ:META) develops a suite of social and communication products-including Facebook, Instagram, Messenger, Threads, and WhatsApp-under its Family of Apps (FoA) segment, while its Reality Labs (RL) segment focuses on consumer hardware, software, and content for virtual, augmented, and mixed reality experiences.
Key recent metrics: Q4 2023 revenue reached $36.3 billion, driven by a 7% year-over-year rise in advertising spend; the company reported 3.1 billion monthly active users across its apps, with Instagram contributing 2 billion MAUs; RL’s capital outlay hit $3.7 billion for the year, reflecting Meta’s bet on the expanding $300 billion AR/VR market projected to grow at ~15% CAGR through 2030.
Macro drivers shaping Meta’s outlook include resilient global digital ad budgets, the gradual shift of advertisers toward short-form video (reels, stories), and the competitive race to monetize immersive platforms as consumer adoption of headsets accelerates.
For a deeper quantitative view, explore the ValueRay dashboard to see how these trends translate into valuation signals.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 58.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -5.62 > 1.0 |
| NWC/Revenue: 19.09% < 20% (prev 36.96%; Δ -17.87% < -1%) |
| CFO/TA 0.35 > 3% & CFO 107.57b > Net Income 58.53b |
| Net Debt (40.87b) to EBITDA (102.75b): 0.40 < 3 |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.57b) vs 12m ago -1.08% < -2% |
| Gross Margin: 82.00% > 18% (prev 0.81%; Δ 8118 % > 0.5%) |
| Asset Turnover: 67.63% > 50% (prev 60.93%; Δ 6.70% > 0%) |
| Interest Coverage Ratio: 88.73 > 6 (EBITDA TTM 102.75b / Interest Expense TTM 959.0m) |
Altman Z'' 4.88
| A: 0.12 (Total Current Assets 73.12b - Total Current Liabilities 36.96b) / Total Assets 303.84b |
| B: 0.33 (Retained Earnings 101.58b / Total Assets 303.84b) |
| C: 0.30 (EBIT TTM 85.09b / Avg Total Assets 280.13b) |
| D: 0.93 (Book Value of Equity 101.74b / Total Liabilities 109.78b) |
| Altman-Z'' Score: 4.88 = AA |
Beneish M -2.97
| DSRI: 0.97 (Receivables 17.30b/14.70b, Revenue 189.46b/156.23b) |
| GMI: 0.99 (GM 82.00% / 81.43%) |
| AQI: 1.17 (AQ_t 0.17 / AQ_t-1 0.15) |
| SGI: 1.21 (Revenue 189.46b / 156.23b) |
| TATA: -0.16 (NI 58.53b - CFO 107.57b) / TA 303.84b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
ValueRay F-Score (Strict, 0-100) 91.20
| 1. Piotroski: 8.50pt |
| 2. FCF Yield: 2.74% |
| 3. FCF Margin: 23.67% |
| 4. Debt/Equity: 0.26 |
| 5. Debt/Ebitda: 0.40 |
| 6. ROIC - WACC: 23.68% |
| 7. RoE: 30.93% |
| 8. Revenue Trend: 90.42% |
| 9. EPS Trend: 75.71% |
What is the price of META shares?
Over the past week, the price has changed by +11.40%, over one month by +2.17%, over three months by -10.30% and over the past year by +2.31%.
Is META a buy, sell or hold?
- Strong Buy: 47
- Buy: 13
- Hold: 6
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the META price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 834.2 | 24% |
| Analysts Target Price | 834.2 | 24% |
| ValueRay Target Price | 937.9 | 39.4% |
META Fundamental Data Overview January 24, 2026
P/E Forward = 20.5761
P/S = 8.616
P/B = 7.9611
P/EG = 1.4493
Revenue TTM = 189.46b USD
EBIT TTM = 85.09b USD
EBITDA TTM = 102.75b USD
Long Term Debt = 28.83b USD (from longTermDebt, last quarter)
Short Term Debt = 2.11b USD (from shortTermDebt, last quarter)
Debt = 51.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 40.87b USD (from netDebt column, last quarter)
Enterprise Value = 1638.98b USD (1632.37b + Debt 51.06b - CCE 44.45b)
Interest Coverage Ratio = 88.73 (Ebit TTM 85.09b / Interest Expense TTM 959.0m)
EV/FCF = 36.55x (Enterprise Value 1638.98b / FCF TTM 44.84b)
FCF Yield = 2.74% (FCF TTM 44.84b / Enterprise Value 1638.98b)
FCF Margin = 23.67% (FCF TTM 44.84b / Revenue TTM 189.46b)
Net Margin = 30.89% (Net Income TTM 58.53b / Revenue TTM 189.46b)
Gross Margin = 82.00% ((Revenue TTM 189.46b - Cost of Revenue TTM 34.11b) / Revenue TTM)
Gross Margin QoQ = 82.03% (prev 82.13%)
Tobins Q-Ratio = 5.39 (Enterprise Value 1638.98b / Total Assets 303.84b)
Interest Expense / Debt = 0.44% (Interest Expense 227.0m / Debt 51.06b)
Taxrate = 11.75% (8.30b / 70.66b)
NOPAT = 75.09b (EBIT 85.09b * (1 - 11.75%))
Current Ratio = 1.98 (Total Current Assets 73.12b / Total Current Liabilities 36.96b)
Debt / Equity = 0.26 (Debt 51.06b / totalStockholderEquity, last quarter 194.07b)
Debt / EBITDA = 0.40 (Net Debt 40.87b / EBITDA 102.75b)
Debt / FCF = 0.91 (Net Debt 40.87b / FCF TTM 44.84b)
Total Stockholder Equity = 189.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.89% (Net Income 58.53b / Total Assets 303.84b)
RoE = 30.93% (Net Income TTM 58.53b / Total Stockholder Equity 189.20b)
RoCE = 39.03% (EBIT 85.09b / Capital Employed (Equity 189.20b + L.T.Debt 28.83b))
RoIC = 34.44% (NOPAT 75.09b / Invested Capital 218.03b)
WACC = 10.77% (E(1632.37b)/V(1683.43b) * Re(11.09%) + D(51.06b)/V(1683.43b) * Rd(0.44%) * (1-Tc(0.12)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.11%
[DCF Debug] Terminal Value 70.78% ; FCFF base≈47.80b ; Y1≈53.75b ; Y5≈71.97b
Fair Price DCF = 347.6 (EV 797.83b - Net Debt 40.87b = Equity 756.96b / Shares 2.18b; r=10.77% [WACC]; 5y FCF grow 14.46% → 2.90% )
EPS Correlation: 75.71 | EPS CAGR: 19.91% | SUE: 1.29 | # QB: 9
Revenue Correlation: 90.42 | Revenue CAGR: 11.85% | SUE: 2.03 | # QB: 2
EPS next Quarter (2026-03-31): EPS=6.35 | Chg30d=+0.049 | Revisions Net=+3 | Analysts=33
EPS next Year (2026-12-31): EPS=29.67 | Chg30d=+0.057 | Revisions Net=+4 | Growth EPS=+29.5% | Growth Revenue=+18.0%
Additional Sources for META Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle